AAPL346.95+3.04 (+0.88%) ▲|ABBV286.48-0.26 (-0.09%) ▼|ABT103.40-1.48 (-1.41%) ▼|ACN236.25-10.98 (-4.44%) ▼|ADBE251.12-7.50 (-2.90%) ▼|AMAT398.08+10.49 (+2.71%) ▲|AMD558.56+27.28 (+5.13%) ▲|AMGN447.01+2.38 (+0.53%) ▲|AMT185.93-2.35 (-1.25%) ▼|AMZN253.31+4.22 (+1.69%) ▲|AVGO341.61+12.44 (+3.78%) ▲|AXP314.18-0.88 (-0.28%) ▼|BA169.85-18.46 (-9.80%) ▼|BAC50.60+0.08 (+0.16%) ▲|BKNG151.78-1.36 (-0.89%) ▼|BLK1,134.93+7.27 (+0.64%) ▲|BMY61.34-0.27 (-0.44%) ▼|BNY147.83+0.65 (+0.44%) ▲|BRK-B544.77-3.79 (-0.69%) ▼|C122.63+1.59 (+1.31%) ▲|CAT712.52+20.39 (+2.95%) ▲|CL92.17-0.94 (-1.00%) ▼|CMCSA21.88-0.18 (-0.79%) ▼|COF204.42+2.07 (+1.02%) ▲|COP148.36-3.01 (-1.99%) ▼|COST991.31-13.86 (-1.38%) ▼|CRM243.11-4.51 (-1.82%) ▼|CSCO112.51+2.27 (+2.05%) ▲|CVS91.79-0.74 (-0.80%) ▼|CVX228.00-4.01 (-1.73%) ▼|DE642.51+1.26 (+0.20%) ▲|DHR232.24-0.73 (-0.31%) ▼|DIS109.57-0.83 (-0.75%) ▼|DUK124.02-0.42 (-0.33%) ▼|EMR164.59+2.89 (+1.79%) ▲|FDX304.59+4.01 (+1.33%) ▲|GD356.19-0.86 (-0.24%) ▼|GE295.92+7.49 (+2.60%) ▲|GEV878.92+24.30 (+2.84%) ▲|GILD157.49-1.21 (-0.76%) ▼|GM81.00+4.69 (+6.15%) ▲|GOOG318.16+3.97 (+1.26%) ▲|GOOGL321.77+4.97 (+1.57%) ▲|GS913.08+19.80 (+2.22%) ▲|HD318.22-1.16 (-0.36%) ▼|HON217.13-2.15 (-0.98%) ▼|IBM249.61-3.83 (-1.51%) ▼|INTC93.99+3.52 (+3.89%) ▲|INTU327.03-12.86 (-3.78%) ▼|ISRG444.77-6.86 (-1.52%) ▼|JNJ267.72+1.42 (+0.53%) ▲|JPM336.11+2.07 (+0.62%) ▲|KO92.13-0.57 (-0.61%) ▼|LIN506.81-0.75 (-0.15%) ▼|LLY1,284.53+5.39 (+0.42%) ▲|LMT628.47-6.73 (-1.06%) ▼|LOW197.14-1.09 (-0.55%) ▼|LRCX241.03+3.53 (+1.49%) ▲|MA610.28-3.22 (-0.52%) ▼|MCD248.78-2.06 (-0.82%) ▼|MDLZ62.30-0.67 (-1.06%) ▼|MDT93.80-0.99 (-1.04%) ▼|META624.85-5.71 (-0.91%) ▼|MMM171.51-1.28 (-0.74%) ▼|MO73.36-0.26 (-0.35%) ▼|MRK142.17+1.56 (+1.11%) ▲|MS187.21+3.72 (+2.03%) ▲|MSFT533.73+1.13 (+0.21%) ▲|MU931.42+27.72 (+3.07%) ▲|NEE82.05+0.01 (+0.01%) ▲|NFLX62.71-1.19 (-1.86%) ▼|NKE37.46-0.46 (-1.20%) ▼|NOW155.95-2.24 (-1.41%) ▼|NVDA218.70+2.70 (+1.25%) ▲|ORCL131.76+5.70 (+4.52%) ▲|PEP133.87-1.59 (-1.17%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG158.48-1.44 (-0.90%) ▼|PLTR201.02+2.18 (+1.10%) ▲|PM203.69+1.82 (+0.90%) ▲|QCOM181.20+1.60 (+0.89%) ▲|RTX195.90-1.58 (-0.80%) ▼|SBUX102.49-0.21 (-0.20%) ▼|SCHW89.61-0.12 (-0.13%) ▼|SO91.87-0.70 (-0.76%) ▼|SPG212.30-0.40 (-0.19%) ▼|T21.07+0.22 (+1.03%) ▲|TMO692.74+7.85 (+1.15%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA406.15+14.53 (+3.71%) ▲|TXN306.47+8.35 (+2.80%) ▲|UBER66.13+0.00 (+0.00%) ▲|UNH409.51-1.20 (-0.29%) ▼|UNP297.85+0.88 (+0.29%) ▲|UPS103.36+3.04 (+3.03%) ▲|USB59.74+0.04 (+0.06%) ▲|V400.76-3.40 (-0.84%) ▼|VZ43.84+0.74 (+1.72%) ▲|WFC82.61-0.04 (-0.05%) ▼|WMT118.94-1.36 (-1.13%) ▼|XOM181.09-3.46 (-1.87%) ▼|AAPL346.95+3.04 (+0.88%) ▲|ABBV286.48-0.26 (-0.09%) ▼|ABT103.40-1.48 (-1.41%) ▼|ACN236.25-10.98 (-4.44%) ▼|ADBE251.12-7.50 (-2.90%) ▼|AMAT398.08+10.49 (+2.71%) ▲|AMD558.56+27.28 (+5.13%) ▲|AMGN447.01+2.38 (+0.53%) ▲|AMT185.93-2.35 (-1.25%) ▼|AMZN253.31+4.22 (+1.69%) ▲|AVGO341.61+12.44 (+3.78%) ▲|AXP314.18-0.88 (-0.28%) ▼|BA169.85-18.46 (-9.80%) ▼|BAC50.60+0.08 (+0.16%) ▲|BKNG151.78-1.36 (-0.89%) ▼|BLK1,134.93+7.27 (+0.64%) ▲|BMY61.34-0.27 (-0.44%) ▼|BNY147.83+0.65 (+0.44%) ▲|BRK-B544.77-3.79 (-0.69%) ▼|C122.63+1.59 (+1.31%) ▲|CAT712.52+20.39 (+2.95%) ▲|CL92.17-0.94 (-1.00%) ▼|CMCSA21.88-0.18 (-0.79%) ▼|COF204.42+2.07 (+1.02%) ▲|COP148.36-3.01 (-1.99%) ▼|COST991.31-13.86 (-1.38%) ▼|CRM243.11-4.51 (-1.82%) ▼|CSCO112.51+2.27 (+2.05%) ▲|CVS91.79-0.74 (-0.80%) ▼|CVX228.00-4.01 (-1.73%) ▼|DE642.51+1.26 (+0.20%) ▲|DHR232.24-0.73 (-0.31%) ▼|DIS109.57-0.83 (-0.75%) ▼|DUK124.02-0.42 (-0.33%) ▼|EMR164.59+2.89 (+1.79%) ▲|FDX304.59+4.01 (+1.33%) ▲|GD356.19-0.86 (-0.24%) ▼|GE295.92+7.49 (+2.60%) ▲|GEV878.92+24.30 (+2.84%) ▲|GILD157.49-1.21 (-0.76%) ▼|GM81.00+4.69 (+6.15%) ▲|GOOG318.16+3.97 (+1.26%) ▲|GOOGL321.77+4.97 (+1.57%) ▲|GS913.08+19.80 (+2.22%) ▲|HD318.22-1.16 (-0.36%) ▼|HON217.13-2.15 (-0.98%) ▼|IBM249.61-3.83 (-1.51%) ▼|INTC93.99+3.52 (+3.89%) ▲|INTU327.03-12.86 (-3.78%) ▼|ISRG444.77-6.86 (-1.52%) ▼|JNJ267.72+1.42 (+0.53%) ▲|JPM336.11+2.07 (+0.62%) ▲|KO92.13-0.57 (-0.61%) ▼|LIN506.81-0.75 (-0.15%) ▼|LLY1,284.53+5.39 (+0.42%) ▲|LMT628.47-6.73 (-1.06%) ▼|LOW197.14-1.09 (-0.55%) ▼|LRCX241.03+3.53 (+1.49%) ▲|MA610.28-3.22 (-0.52%) ▼|MCD248.78-2.06 (-0.82%) ▼|MDLZ62.30-0.67 (-1.06%) ▼|MDT93.80-0.99 (-1.04%) ▼|META624.85-5.71 (-0.91%) ▼|MMM171.51-1.28 (-0.74%) ▼|MO73.36-0.26 (-0.35%) ▼|MRK142.17+1.56 (+1.11%) ▲|MS187.21+3.72 (+2.03%) ▲|MSFT533.73+1.13 (+0.21%) ▲|MU931.42+27.72 (+3.07%) ▲|NEE82.05+0.01 (+0.01%) ▲|NFLX62.71-1.19 (-1.86%) ▼|NKE37.46-0.46 (-1.20%) ▼|NOW155.95-2.24 (-1.41%) ▼|NVDA218.70+2.70 (+1.25%) ▲|ORCL131.76+5.70 (+4.52%) ▲|PEP133.87-1.59 (-1.17%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG158.48-1.44 (-0.90%) ▼|PLTR201.02+2.18 (+1.10%) ▲|PM203.69+1.82 (+0.90%) ▲|QCOM181.20+1.60 (+0.89%) ▲|RTX195.90-1.58 (-0.80%) ▼|SBUX102.49-0.21 (-0.20%) ▼|SCHW89.61-0.12 (-0.13%) ▼|SO91.87-0.70 (-0.76%) ▼|SPG212.30-0.40 (-0.19%) ▼|T21.07+0.22 (+1.03%) ▲|TMO692.74+7.85 (+1.15%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA406.15+14.53 (+3.71%) ▲|TXN306.47+8.35 (+2.80%) ▲|UBER66.13+0.00 (+0.00%) ▲|UNH409.51-1.20 (-0.29%) ▼|UNP297.85+0.88 (+0.29%) ▲|UPS103.36+3.04 (+3.03%) ▲|USB59.74+0.04 (+0.06%) ▲|V400.76-3.40 (-0.84%) ▼|VZ43.84+0.74 (+1.72%) ▲|WFC82.61-0.04 (-0.05%) ▼|WMT118.94-1.36 (-1.13%) ▼|XOM181.09-3.46 (-1.87%) ▼|
14.6 C
New York
Tuesday, October 27, 2026

Tag: regulations

newsFORsourcecompanycontentinformation1releasesmarket

Temu Partners with Spain’s Recyclia to Support Seller Extended Producer Responsibility

MADRID, Oct. 26, 2026 /PRNewswire/ -- Temu has signed an agreement with Recyclia, which administers the Ecoasimelec and Ecopilas collective extended producer responsibility (EPR)...

AUTOCRYPT Highlights V2X Security Technologies and C-ITS Research Initiatives at ITS World Congress 2026

SEOUL, South Korea, Oct. 26, 2026 /PRNewswire/ -- AUTOCRYPT, a leading Physical AI security solutions provider, showcased its comprehensive Vehicle-to-Everything (V2X) security solutions, automotive...

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer

Responses were deep and durable, with 65% ongoing at clinical cutoffResults support continued evaluation of the investigational RYBREVANT FASPRO regimen in the ongoing first-line Phase...

Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule

JNJ-6143 is an investigational, once-daily, novel, small molecule designed to trigger cancer cell death through a targeted dual-protein lock between BRD4 and androgen receptor,...

Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk...

New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ADT compared with immediate surgeryTwice as...

Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026

GUANGZHOU, China, Oct. 24, 2026 /PRNewswire/ -- Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced the presentation...

/C O R R E C T I O N – DigitalXForce Corporation/

In the news release, DigitalXForce Scores Triple Win: IDC MarketScape Leader Recognition, Institutional Investment from Arsenal Equity Group and 514% Growth, issued 21-Oct-2026 by...

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Research Will Use Lunit's AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment BiologySEOUL, South Korea, Oct. 24,...

Orex Minerals Announces Repricing of Warrants

VANCOUVER, BC, Oct. 23, 2026 /CNW/ -- Orex Minerals Inc. (TSXV: REX) ("Orex" or the "Company") announces that, subject to acceptance by the TSX Venture Exchange (the...

U.S. FDA Approves Subcutaneous Induction Regimen for AbbVie’s SKYRIZI® (risankizumab-rzaa) for Adults With Moderately to Severely Active Crohn’s Disease

Now with a new route of induction administration, subcutaneous SKYRIZI supports early symptomatic and endoscopic control with an on-body injector (OBI) device throughout the...

UCB Establishes the Emmanuel Janssen Endowed Chair for the Evaluation of Medicines at Brigham and Women’s Hospital

Permanent endowment advances pharmacoepidemiology and real-world evidence researchSebastian Schneeweiss, MD, ScD, an internationally recognized pharmacoepidemiologist whose research focuses on improving medication safety, effectiveness, and...

Abbott presents new ESMO data showing 30-percent absolute improvement in sensitivity with the whole-genome sequencing Oncodetect® test in colorectal cancer

Beta-CORRECT study shows a 10.6-fold higher risk of recurrence, reinforcing the prognostic value of molecular residual disease (MRD) testing1Building on its leadership in colorectal...

Primis Financial Corp. Reports Strong Results for the Third Quarter of 2026

Declares Quarterly Cash Dividend of $0.10 Per ShareMCLEAN, Va., Oct. 22, 2026 /PRNewswire/ -- Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company"), and...

Collective Mining Files NI 43-101 Technical Report for Maiden Mineral Resource for the Apollo Deposit

MIAMI, Oct. 22, 2026 /CNW/ -- Collective Mining Ltd. (NASDAQ: CNL) (TSX: CNL) ("Collective" or the "Company") is pleased to announce that it has filed...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRegulations

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers